The Blood and Tissue Core provides an essential resource for local and collaborative research. The Core is designed to exist as a "core without walls". The primary responsibility ofthe Core is to ensure the quality of processing and storage of human specimens. We work closely with the Massachusetts General Hospital's NIH-funded Chnical Research Center (CRC) which is part of the Harvard Clinical and Translational Science Center (CTSC), and we have established collaboration with Dr. James Liao's laboratory at the BWH. We propose a Blood and Tissue Core responsive to the aims set forth in the Specialized Program of Translational Research in Acute Stroke program announcement (PAR-09-254), which will support ARISE (project #2) at MGH and Neu-START at BWH, and collect and share plasma and DNA samples within the SPOTRIAS network.
The aims ofthe Partners SPOTRIAS Blood and Tissue Core are: 1. To process, maintain, and distribute blood specimens collected in ARISE (Project #2) at MGH. 2. To support blood collection and processing for the Neu-START study at the BWH. 3. To store blood specimens collected on SPOTRIAS subjects for future collaborative studies. 4. To collect genetic material for submission to the NINDS repository for use in future genetic studies proposed within Partners, the SPOTRIAS network, the International Stroke Genetics Consortium (ISGC), and the broader scientific community.

Public Health Relevance

Biomarkers in acute stroke appear promising in developing targets for neuroprotective therapies, monitoring response to treatment and as surrogate endpoints for clinical trials. For example, hemostatic and inflammatory biomarkers appear to correlate with response to thrombolysis, infarct progression and hemorrhage transformation. Future studies in acute stroke are needed to define their role in clinical practice.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS051343-09
Application #
8484460
Study Section
Special Emphasis Panel (ZNS1-SRB-R)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
9
Fiscal Year
2013
Total Cost
$77,633
Indirect Cost
$33,772
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Matsouaka, Roland A; Betensky, Rebecca A (2015) Power and sample size calculations for the Wilcoxon-Mann-Whitney test in the presence of death-censored observations. Stat Med 34:406-31
Brouwers, H Bart; Raffeld, Miriam R; van Nieuwenhuizen, Koen M et al. (2014) CT angiography spot sign in intracerebral hemorrhage predicts active bleeding during surgery. Neurology 83:883-9
Brouwers, H Bart; Chang, Yuchiao; Falcone, Guido J et al. (2014) Predicting hematoma expansion after primary intracerebral hemorrhage. JAMA Neurol 71:158-64
Radmanesh, Farid; Devan, William J; Anderson, Christopher D et al. (2014) Accuracy of imputation to infer unobserved APOE epsilon alleles in genome-wide genotyping data. Eur J Hum Genet 22:1239-42
Boulouis, Grégoire; Dumas, Andrew; Betensky, Rebecca A et al. (2014) Anatomic pattern of intracerebral hemorrhage expansion: relation to CT angiography spot sign and hematoma center. Stroke 45:1154-6
Kimberly, W Taylor; Battey, Thomas W K; Pham, Ly et al. (2014) Glyburide is associated with attenuated vasogenic edema in stroke patients. Neurocrit Care 20:193-201
Ruff, Ilana M; Ali, Syed F; Goldstein, Joshua N et al. (2014) Improving door-to-needle times: a single center validation of the target stroke hypothesis. Stroke 45:504-8
Boltze, Johannes; Ayata, Cenk; Wagner, Daniel-Christoph et al. (2014) Preclinical phase III trials in translational stroke research: call for collective design of framework and guidelines. Stroke 45:357
Mormino, Elizabeth C; Betensky, Rebecca A; Hedden, Trey et al. (2014) Amyloid and APOE ?4 interact to influence short-term decline in preclinical Alzheimer disease. Neurology 82:1760-7
Opherk, Christian; Gonik, Mariya; Duering, Marco et al. (2014) Genome-wide genotyping demonstrates a polygenic risk score associated with white matter hyperintensity volume in CADASIL. Stroke 45:968-72

Showing the most recent 10 out of 73 publications